Improving patient selection for immuno‐oncology phase 1 trials: External validation of six prognostic scores in a French Cancer Center-Reference-Cited by-同舟云学术

Improving patient selection for immuno‐oncology phase 1 trials: External validation of six prognostic scores in a French Cancer Center

Published:2020-12-06 Issue:10 Volume:148 Page:2502-2511
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Al Darazi Ghassan¹,Martin Elodie²,Delord Jean‐Pierre¹,Korakis Iphigenia¹,Betrian Sarah¹,Estrabaut Myriam³,Poublanc Muriel³,Gomez‐Roca Carlos¹,Filleron Thomas²^ORCID

Affiliation:

1. Department of Medical Oncology Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse—Oncopole (IUCT‐O) Toulouse France

2. Department of Biostatistics Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse—Oncopole (IUCT‐O) Toulouse France

3. Clinical Research Department Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse—Oncopole (IUCT‐O) Toulouse France

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33409

Reference46 articles.

1. Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study

2. Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies

3. Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

4. Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

5. PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-Analysis;Cancers;2024-05-11

2. Association between ascites Gustave Roussy immune score and the intratumoural microbiome in malignant ascites secondary to hepatocellular carcinoma;International Immunopharmacology;2024-05

3. Comparison of Prognostic Scores in Early Phase Clinical Trials: A 10-year Single Centre Australian Experience;Anticancer Research;2024-04-27

4. Prognosis stratification of cancer patients treated with immune checkpoint inhibitors through lung immune prognostic index: a meta-analysis and systematic review;BMC Cancer;2024-04-25

5. Association of the Advanced Lung Cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer;BMC Cancer;2024-04-08